| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.54▲ | 0.55▲ | 0.55▲ | 0.55▼ | 0.50▲ |
| MA10 | 0.54▲ | 0.55▼ | 0.55▼ | 0.54▲ | 0.46▲ |
| MA20 | 0.55▼ | 0.55▼ | 0.55▲ | 0.52▲ | 0.49▲ |
| MA50 | 0.55▼ | 0.53▲ | 0.53▲ | 0.47▲ | 0.65▼ |
| MA100 | 0.53▲ | 0.53▲ | 0.52▲ | 0.50▲ | 1.80▼ |
| MA200 | 0.53▲ | 0.50▲ | 0.48▲ | 0.60▼ | 4.74▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.002▼ | -0.001▼ | 0.001▲ | 0.037▲ |
| RSI | 49.363▼ | 51.583▲ | 52.090▲ | 55.119▲ | 47.389▼ |
| STOCH | 38.774 | 41.524 | 41.524 | 65.488 | 34.162 |
| WILL %R | -66.875 | -64.793 | -64.793 | -33.568 | -52.636 |
| CCI | -26.415 | -32.241 | -35.270 | 46.422 | 114.350▲ |
|
Tuesday, August 19, 2025 05:28 AM
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used to deliver BX004; no concerns were raised in the clinical hold ...
|
|
Wednesday, July 23, 2025 09:00 AM
GAITHERSBURG, Md., Aug. 08, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that ...
|
|
Monday, June 16, 2025 12:04 PM
BiomX Inc. (NYSE: PHGE)* has achieved what Big Pharma couldn't accomplish in over 20 years — successful clinical trials using viruses to treat life-threatening infections that no longer respond ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/08/25 | 0.5351 | 0.5457 | 0.5351 | 0.5457 | 148,782 |
| 26/08/25 | 0.556 | 0.57 | 0.534 | 0.558 | 406,900 |
| 25/08/25 | 0.57 | 0.57 | 0.541 | 0.55 | 617,500 |
| 22/08/25 | 0.543 | 0.56 | 0.52 | 0.547 | 495,800 |
| 21/08/25 | 0.512 | 0.556 | 0.505 | 0.541 | 450,000 |
| 20/08/25 | 0.543 | 0.543 | 0.51 | 0.52 | 346,600 |
| 19/08/25 | 0.49 | 0.55 | 0.473 | 0.548 | 1,073,800 |
| 18/08/25 | 0.538 | 0.548 | 0.51 | 0.522 | 585,400 |
| 15/08/25 | 0.498 | 0.5695 | 0.498 | 0.558 | 1,202,797 |
| 14/08/25 | 0.4925 | 0.5204 | 0.4921 | 0.5031 | 908,816 |
|
|
||||
|
|
||||
|
|